Nestle S.A. (NESN)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026
Key indicators
| Last close | CHF 84.37 |
|---|---|
| 52-week range | 70.29 – 87.09 |
| Return, 1 month / 3 months | +9.4% / −2.1% |
| Return, 1 year / 3 years | +7.3% / −4.6% |
| Trend | Uptrend |
| RSI (14) | 77 |
| Volatility (1 year) | 21.2% |
| Worst drawdown (1 year) | -13.6% |
| Average daily value traded | 238.82M CHF |
| Dividend yield | 3.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nestlé is a Swiss consumer goods company based in Vevey. It makes and sells food and drink products, including coffee, bottled water, infant nutrition, breakfast cereals, confectionery and pet food. Its customers are households worldwide, reached through supermarkets, shops and other retailers, and it also supplies food and beverage products to businesses such as cafes and restaurants. The company operates across many countries and manages a broad portfolio of brands in everyday nutrition and household staples.
Nestle S.A. trades under the code NESN on the SIX Swiss Exchange in Switzerland, with its price quoted in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Nestle S.A. (NESN) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 84.37 on 22 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 32 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.3% and over the last three months it fell 2.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 8.1% | ||
| From 52-week high | -2.1% | ||
| Momentum | 46 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -2.1% | ||
| 6-month return | 11.7% | ||
| 12-month return, skipping the last month | -2.0% | ||
| Stability (higher is calmer) | 80 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.6% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 238.82M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 67 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.7% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +4.1% |
|---|---|
| 1 month | +9.4% |
| 3 months | −2.1% |
| 6 months | +11.7% |
| 1 year | +7.3% |
| 3 years | −4.6% |
| 5 years | −15.7% |
Signals
| 50-day / 200-day average | 78.40 / 78.03 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.30 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Apr 2026 | CHF 3.1000 |
| 22 Apr 2025 | CHF 3.0500 |
| 22 Apr 2024 | CHF 3.0000 |
| 24 Apr 2023 | CHF 2.9500 |
| 11 Apr 2022 | CHF 2.8000 |
| 19 Apr 2021 | CHF 2.7500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.